CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,467 Cr | ₹1,269 Cr | ₹1,061 Cr | ₹86,320 Cr | ₹649 Cr |
What is the latest Revenue of CAPLIN POINT LABORATORIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,467 Cr |
Mar2023 | ₹1,269 Cr |
Mar2022 | ₹1,061 Cr |
Mar2021 | ₹86,320 Cr |
Mar2020 | ₹649 Cr |
How is Revenue of CAPLIN POINT LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,467 Cr | 15.54 | |
Mar2023 | ₹1,269 Cr | 19.61 | |
Mar2022 | ₹1,061 Cr | -98.77 | |
Mar2021 | ₹86,320 Cr | 13,206.82 | |
Mar2020 | ₹649 Cr | - |
Compare Revenue of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,030.5 Cr | -0.5% | 8.5% | 50.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -0.5% |
8.5% |
50.2% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses